Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The dose is gradually increased over several weeks to minimise side effects and allow the body to adjust to the medication
Some medications in this class have demonstrated up to 15-21% weight loss over 68 weeks in clinical studies, but every individual's experience is different
subjects given the botanical combination lost an average of about 11 pounds and about 4 inches in both waist and hip circumference
Do not rely on thirst to tell you when to drink
The conditions that most commonly support eligibility include: Obesity (BMI 30, or 27 with at least one comorbidity such as hypertension, sleep apnea, or cardiovascular disease) Type 2 diabetes or prediabetes Insulin resistance with clinical documentation Metabolic syndrome (clinically diagnosed) Polycystic Metabolic Ovarian Syndrome (PMOS) and related hormonal disorders Non-alcoholic fatty liver disease (NAFLD/MASLD) Perimenopause-related metabolic dysfunction with documented hormonal changes GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide are the most commonly used peptides in metabolic care today
US$ 29.44
US$ 28.28
US$ 26.34
